Biotechs by market cap

There are two types of biotechs in market. The bigger established companies like AMGN, BIIB, CELG, REGN, VRTX and ALXN have real revenue. The second category of biotechs are developmental stage biotechs that trade mostly based on expectations of FDA approval or results of clinical trial.   

Symbol    Company name Mkt Cap  ▼

1. JNJ            Johnson & Johnson  243.87B
2. RHHBY Roche Holding Ltd 227.58B
3. PFE Pfizer Inc.              205.99B
4. NVS   Novartis                            179.50B  (profile) (news)
5. SNY Sanofi SA (ADR)             145.19B
6. MRK Merck & Co., Inc.    137.34B
7. GSK GlaxoSmithKline                130.52B
8. ABT Abbott Laboratories          107.59B
9. AMGN      Amgen                                 74.43B
10. BMY Bristol Myers Squibb Co.     77.86B
11. AZN AstraZeneca plc                    65.20B
12. LLY           Eli Lilly                                 60.99B (profile) (news)
13. BIIB          Biogen                                   54.13B (profile) (news)
14. CELG        Celgene                                49.41B (profile) (news)
15. AGN          Allergan                               29.05B
16. VRX           Valeant                                25.66B  (profile) (news)
17. ALPMY ASTELLAS PHARMA 24.45B
18. WPI Watson Pharmaceuticals      10.87B
19. MYL Mylan Inc.                            9.89B
20. ILMN        Illumina                                 8.07B   (profile) (news)
21. ONXX       Onyx                                 6.54B   (profile) (news)
22. MDVN Medivation 3.55B    (profile) (news)
23. CLDX   Celldex Therapeutics            1.72B    (profile) (news)
24. EXEL   Exelixis                                858.35M    (profile) (news)
25. DNDN Dendreon                        742.49M  (profile) (news)
26. SPPI Spectrum Pharmaceuticals   734.07M  (profile) (news)
27. IDIX          Idenix                                  693.91M  (profile) (news)
28. ECYT    Endocyte, Inc. 523.72M
29. AVNR Avanir Pharmaceuticals   471.19M   (profile) (news)
30. BCRX       BioCryst                             311.97M   (profile) (news)
31. GTXI GTx, Inc. 287.70M
32. ARQL ArQule 148.42M
33. AVEO AVEO 137.37M
34. CORX Cortex Pharmaceut... 8.51M
35. HRBR Harbor Diversifie... 6.03M
36. ALSE Alseres Pharmaceu... 4.29M
37. EPIX EPIX Pharmaceuticals     .. 112,164.00

Acquisitions

1. Stryker (SYK) to acquire MAKO Surgical (MAKO) for $1.65 billion (9/25/13)
2. Allos Therapeutics Inc. acquired by Spectrum Pharmaceuticals - purchase completed 9/5/12
3. Celgene (CELG) acquired Avila Therapeutics in March 2012.